At #sir24slc the Asia Pacific exec met with SIR exec to discuss strategy for asia pacificIR, I got to join in the plenary session today for a fun IR quiz on “team international” and there was great content on knee embolisation at the GAE session from an all star panel. @IRSA_IRs

Great to connect with IRs across the US at #SIR24SLC for #IRSA. I’m excited by advances in Embolisation, AR, AI and robotics which will advance IR.

Most people have never heard of interventional radiology and the many minimally invasive image guided procedures which it can offer to solve a variety of medical conditions. Technology drives continuous innovation and this brings with it new options for patients every year.

RT @IRSA_IRs: We're reaching the grand finale at the #IRSA2023SYD! Day 3 is buzzing with talks by top IR experts, unveiling cutting-edge me….

Official opening of our new interventional oncology facility this week at Chris O’Brien Lifehouse cancer centre in Sydney! I believe that minimally invasive image guided approaches to treatment of cancer benefits patients and needs more awareness.

RT @Warren_IR: 🚨 New article alert 🚨.The first A/NZ guideline on fibroid embolisation, written by IRs, for IRs. We must control the governa….

We had a fun and provocative conversation on the future of surgery which I think is minimally invasive, guided by state of the art imaging (AR,3D) as well as deep but usable data informed by AI and creative thought process. All of that with the patient relationship at the centre!.

Ablation outcomes continuously improving, driven by better case selection, technical advances and catheter imaging. I think advanced imaging with hybrid angioCT suites and fusion will improve margins and allow cures to be obtained in the majority of patients if well selected.

RT @_backtable: Check out our new search engine for open access resources to help you find what you're looking for quick and easy- test it….

survival and almost three times longer overall survival with the addition of TACE to their standard chemotherapy. There was a low rate of serious complications. 25% of patients were downstaged to resectable vs 8% for IV chemo alone.

I think this recent paper on liver directed minimally invasive therapy for Cholangiocarcinoma (TACE) is quite compelling. This was a randomised controlled trial and showed that patients with this form of liver cancer had three times longer progression fre…